-- Shaanxi Energy Investment's (SHE:001286) attributable profit rose 26% to 887.9 million yuan in the first quarter from 703 million yuan in the year-ago period, according to a Tuesday filing with the Shenzhen bourse.
Earnings per share at the thermal and coal power generation company increased 26% to 0.24 yuan from 0.19 yuan in the prior-year period.
Operating income grew 11% year over year to 5.78 billion yuan from 5.20 billion yuan.
Avricore Health (AVCR.V) said Tuesday that its HealthTab platform has now screened more than 3,500 patients in community pharmacies across North East and North Central London.The company also updated its expansion strategy for its HealthTab point-of-care testing platform in the UK. HealthTab launched HbA1c testing for diabetes screening in the first quarter of this year, and UACR kidney function testing is planned for the third quarter of this year. During an initial one-month pilot of HbA1c testing, the company completed 2,295 HbA1c tests for diabetes across 57 locations, a statement said.Avricore expects its current pilots to expand to more than 100 pharmacy sites in the second quarter, with monthly subscription revenue expected to begin in the second half of 2026.The company, which is targeting 500 or more active UK locations by mid-2027, is forecasting a return to profitability by the third quarter of next year.It noted that from September, all newly qualified pharmacists in England will graduate as independent prescribers, which will strengthen the clinical role of community pharmacy and supports the broader adoption of point-of-care testing infrastructure such as HealthTab.Avricore shares closed unchanged at $0.065, on the TSX Venture Exchange on Monday.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:DHI reported mixed Q2 FY 26 (Sep.) results with closings up 1% to 19,486 homes but revenue down 2% to $7.0B due to a 3% decline in average selling prices to $362K. EPS of $2.24 beat consensus of $2.12 despite falling 13% as net income dropped 20% to $647.9M, while homebuilding pre-tax margin compressed 230 bps to 10.7%. We see DHI differentiating itself from peers through market share gains, evidenced by accelerated order value growth despite elevated sales incentives. Management updated FY 26 guidance to $33.5B-$34.5B in revenues and 86K-87.5K homes closed, acknowledging incentives will remain elevated through FY 26. Net sales orders accelerated 11% to 24,992 homes valued at $9.2B, though demand remains softer than historical seasonality. The sales backlog of 16,882 homes worth $6.4B provides improved visibility, up 19% and 17%, respectively. We believe DHI's value proposition continues resonating with consumers despite mortgage rate uncertainty impacting seasonal demand patterns.
Crisil kept its A+ long-term rating and A1+ short-term rating on the bank loan facilities of the jute goods maker Cheviot (NSE:CHEVIOT, BOM:526817).The rating outlook is stable, according to a Tuesday filing.